Results 111 to 120 of about 23,951 (282)

Development of a Uniform Apheresis Case Report Form for Standardized Collection of Apheresis Data

Apheresis is performed worldwide for an increasing number of indications. The development of common data elements (CDE) for apheresis related areas may facilitate conduct of new research, enhance quality initiatives including benchmarking, and improve ...
Balogun, Rasheed A, Wu, Yanyun, Winters, Jeffrey L, Pederson, Thomas, Szczepiorkowski, Zbigniew M, Johnson, Andrew D, Burgstaler, Edwin, Chlebeck, Therese, Nellis, Marianne, Pavenski, Katerina, Armendariz, Tomas, Geile, Kira, Sanchez, Amber P, Collins, Laura, Witt, Volker, Thao, Mai, Schneiderman, Jennifer, Schwartz, Joseph, Zantek, Nicole D, Muthusamy, Amutha, Karam, Oliver, Ramesh, Vidhyalakshmi   +21 more
core   +1 more source

Discussion on the recruitment strategy for apheresis platelet donors in Chongqing during a public health emergency*

Frontiers in Public Health
ObjectiveThis study aimed to analyze the population characteristics of apheresis platelet donors in Chongqing Province and provide a scientific basis for the development of precise and efficient recruitment strategies.
Ying Cheng, Chengbing Xie, Yunbo Tian, Fang Wang, Xingchen Liu, Danfeng Cheng   +5 more
doaj   +1 more source

Correlation of CD34+ Hematopoietic Stem Cells and CFU in Peripheral Blood Apheresis Products in Patients with Malignant Lymphoproliferative Diseases Before and After Cryopreservation Prior to auto-HSCT

Клиническая онкогематология, 2018
Aim. To establish correlation between CD34+ autologous hematopoietic stem cell (HSC) count and colony-forming units (CFU) in the same peripheral blood apheresis product samples before and after cryopreservation in multiple myeloma and lymphoma patients ...
Valentina Andreevna Balashova, V. I. Rugal’, S. S. Bessmel’tsev, S. V. Gritsaev, N. Yu. Semenova, S. V. Voloshin, Zh. V. Chubukina, A. V. Shmidt, A. D. Garifullin, I. M. Zapreeva, A. A. Kuzyaeva, I. I. Kostroma, A. Yu. Kuvshinov, A. V. Chechetkin   +13 more
doaj   +1 more source

Chagas disease in Canadian blood donors: 15 years of selective testing

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Chagas disease (Trypanosoma cruzi), prevalent in Mexico, Central and South America, can be transfusion‐transmitted. Selective serological testing of blood donors was implemented over 15 years ago. We describe the trends in infections and characteristics of donors selected for testing.
Sheila F. O'Brien, Mindy Goldman, Antoine Lewin, Samra Uzicanin, Wenli Fan, Steven J. Drews   +5 more
wiley   +1 more source

Impact of a national donor vigilance system: An example of improved donor health by reduction of delayed bleedings after donor plasmapheresis

Vox Sanguinis, EarlyView.
Abstract Background and Objectives In Denmark, all blood banks use the same standardized donor vigilance system, enabling comparisons of adverse reactions across the country's five regions. At several collection sites, a compression bandage is applied over the venipuncture site after donation.
Pia Braagaard Hartfelt, Christina Mikkelsen, Bitten Aagaard, Rune Larsen, Sys Hasslund, Louise Ørnskov Drechsler, Mark H. Yazer, Mie Topholm Bruun   +7 more
wiley   +1 more source

Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates

, 2017
Platelet storage lesion is characterized by morphological changes and impaired platelet function. The collection method and storage medium may influence the magnitude of the storage lesion.
Andersson Shams Hakimi, Caroline,, Sukhi Singh, Singh, Sukhi,, Camilla Hesse, Caroline Shams Hakimi, Hesse, Camilla,, Anders Jeppsson, Jeppsson, Anders,   +7 more
core   +1 more source

Navigating the Post‐BCMA/GPRC5D Landscape: Efficacy of Selinexor, Bortezomib, and Dexamethasone After Sequential Immunotherapy Failure in Penta‐Refractory Multiple Myeloma—A Multicenter Analysis

American Journal of Hematology, Volume 101, Issue 7, Page 1433-1439, July 2026.
ABSTRACT Patients with relapsed/refractory multiple myeloma (RRMM) who are penta‐drug refractory, defined as resistant to two proteasome inhibitors, two immunomodulatory agents, and an anti‐CD38 monoclonal antibody, face a dismal prognosis, particularly after exposure to T‐cell–redirecting therapies.
Maximilian Al‐Bazaz, Winfried Alsdorf, Lisa Leypoldt, Piet Sonnemann, Christoph Schaefers, Jule Artzenroth, Marie Harzer, Abdulaziz Kamili, Leandra Bartke, Leon Cords, Jan Vorwerk, Theo Leitner, Markus Maulhardt, Kerstin Brinkert, Annamaria Brioli, Tim Richardson, Udo Holtick, Stefan M. Hillmann, Hans Salwender, Cyrus Khandanpour, Carsten Bokemeyer, Katja Weisel, Ricardo Kosch   +22 more
wiley   +1 more source

The number of apheresis procedures to treat immune-mediated neurological diseases is on the rise

Apheresis is used for the treatment of many different diseases, especially when conventional therapy lacks efficacy. There are however some diseases in which apheresis is accepted as first line therapy. The aim of this analysis was to investigate the use
Kielstein, Jan, Skosana, Yona, Deeren, Dries, Le Poole, Kaatje, Griscevicius, Antanas, Witt, Volker, Svenningsson, Anders, Glatt, Tanya Nadia, Lanska, Miriam, Aandahl, Astrid, Berlin, Gösta, Vrielink, Hans, Newman, Elizabeth, Ott, Michael, Gasova, Zdenka, Cengiz, Guldane, Seval, Guldane Cengiz, Audzijoniene, Judita, Ludvikova, Zdenka Bhuiyanova, Hridlickova, Radomira, Stegmayr, Bernd, Blahutova, Sarka   +21 more
core   +1 more source

Challenges, Difficulties, and Delayed Diagnosis of Multiple Myeloma

Diagnostics
Background: Multiple myeloma (MM) is a heterogeneous plasma cell malignancy with non-specific symptoms and disease heterogeneity at clinical and biological levels.
Tugba Zorlu, Merve Apaydin Kayer, Nazik Okumus, Turgay Ulaş, Mehmet Sinan Dal, Fevzi Altuntas   +5 more
doaj   +1 more source

Dissecting Pirtobrutinib Resistance in Mantle Cell Lymphoma Through Single‐Cell Multi‐Omics

American Journal of Hematology, Volume 101, Issue 7, Page 1632-1649, July 2026.
ABSTRACT Pirtobrutinib (PBN), a non‐covalent BTK inhibitor, has been approved by the FDA for relapsed/refractory mantle cell lymphoma (MCL); however, resistance to PBN has been observed. To dissect the molecular dynamics driving PBN resistance, we performed integrative single‐cell multi‐omic profiling (scRNA‐seq, scATAC‐seq, and scDNA‐seq) on ...
Fangfang Yan, Yang Liu, Heng‐Huan Lee, Wei Wang, Joseph McIntosh, Yijing Li, Jovanny Vargas, Yue Fei, Sairah Ahmed, Lukas M. Simon, Michael Wang   +10 more
wiley   +1 more source